Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

No Dominant Sponsors In US FDA's 2016 Novel Approvals Class

Jan 06 2017

• By Bridget Silverman

Biopharma In Perspective 2016-2017

Related Content

New Drugs And Biologics Approved By US FDA In 2016

Jan 06 2017

Novel Approvals Were Fewer But Faster At US FDA In 2016

Jan 02 2017

Pfizergan Would Have Challenged Novartis For 2015 Approvals Crown

Jan 25 2016

Related Companies

Novartis AG

Allergan plc

Amgen, Inc.

Roche Holding AG

Genentech, Inc.

AbbVie Inc.

Merck & Co., Inc.

Eli Lilly and Company

Biogen, Inc.

CSL Limited

Takeda Pharmaceutical Co. Ltd.

Baxalta Incorporated

Sarepta Therapeutics, Inc.

Clovis Oncology, Inc.

Intercept Pharmaceuticals, Inc.

Elusys Therapeutics, Inc.

Blue Earth Diagnostics

Advanced Accelerator Applications SA

Additional Topics

United States Approvals Regulation BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window